Flavoxate Hydrochloride NDC 24658-720

NDC codes

FDA NDC Directory

Product NDC (as listed)24658-720Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24658-0720Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24658-720-01	24658072001	100 TABLET in 1 BOTTLE (24658-720-01)Marketed from Dec 15, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Flavoxate Hydrochloride
Generic name (nonproprietary): flavoxate hydrochloride
Active ingredients: Flavoxate hydrochloride — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: PuraCap Laboratories LLC dba Blu Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076835
Marketing start: Dec 15, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 24658-720_cdb3dd6e-969c-4f0c-888b-a3e1b7062fdaSPL ID cdb3dd6e-969c-4f0c-888b-a3e1b7062fdaSPL set ID f6a06eda-2480-4c0d-8d1e-9e3e89d3ee88RxCUI 1095229UNII 9C05J6089WUPC 0324658720012
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424658072001 followed by a unit qualifier and the quantity

Package 24658-0720-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 11, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Flavoxate hydrochloride tablets are indicated for symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis. Flavoxate hydrochloride tablets are not indicated for definitive treatment, but are compatible with drugs used for the treatment of urinary tract infections.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 076835

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 076835
Product	Strength	Form · route	Labeler	Product NDC
Flavoxate Hydrochloride	Flavoxate hydrochloride 100 mg/1	TabletOral	Epic Pharma, LLC	42806-058